HK27584A - Peptides - Google Patents

Peptides

Info

Publication number
HK27584A
HK27584A HK275/84A HK27584A HK27584A HK 27584 A HK27584 A HK 27584A HK 275/84 A HK275/84 A HK 275/84A HK 27584 A HK27584 A HK 27584A HK 27584 A HK27584 A HK 27584A
Authority
HK
Hong Kong
Prior art keywords
peptides
Prior art date
Application number
HK275/84A
Other languages
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of HK27584A publication Critical patent/HK27584A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK275/84A 1976-03-23 1984-03-22 Peptides HK27584A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51032170A JPS5944308B2 (ja) 1976-03-23 1976-03-23 ペプタイド

Publications (1)

Publication Number Publication Date
HK27584A true HK27584A (en) 1984-03-30

Family

ID=12351453

Family Applications (1)

Application Number Title Priority Date Filing Date
HK275/84A HK27584A (en) 1976-03-23 1984-03-22 Peptides

Country Status (19)

Country Link
US (1) US4100152A (sv)
JP (1) JPS5944308B2 (sv)
AT (1) AT360674B (sv)
AU (1) AU508387B2 (sv)
BE (1) BE852740A (sv)
CA (1) CA1060435A (sv)
CH (1) CH634548A5 (sv)
DE (1) DE2712086C2 (sv)
DK (1) DK149111C (sv)
FR (1) FR2345448A1 (sv)
GB (1) GB1579264A (sv)
GR (1) GR62565B (sv)
HK (1) HK27584A (sv)
HU (1) HU177515B (sv)
MY (1) MY8500264A (sv)
NL (1) NL188412C (sv)
SE (1) SE430601B (sv)
SG (1) SG76083G (sv)
ZA (1) ZA771495B (sv)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
US4591648A (en) * 1981-04-01 1986-05-27 National Research Development Corp. Histidine protection
US4426378A (en) 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant
JPS5849313A (ja) * 1981-09-16 1983-03-23 Takeda Chem Ind Ltd 抗てんかん剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
GB2146026A (en) * 1983-09-07 1985-04-11 Tanabe Seiyaku Co Peptides and process for preparing the same
JPS60190795A (ja) * 1984-03-09 1985-09-28 Takeda Chem Ind Ltd ペプタイド
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
IL75641A (en) * 1984-07-10 1990-11-05 Tanabe Seiyaku Co 1-methyl-4,5-dihydro-orotyl-histidyl-prolinamide,its preparation and pharmaceutical compositions comprising it
GB2171101A (en) * 1985-02-20 1986-08-20 Tanabe Seiyaku Co Peptide and processes for preparation of the same
FR2585709B1 (fr) * 1985-08-05 1987-10-02 Adir Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2526589B2 (ja) * 1986-08-08 1996-08-21 武田薬品工業株式会社 ペプチド含有マイクロカプセルおよびその製造法
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
JPS63316724A (ja) * 1987-06-19 1988-12-26 Nippon Shinyaku Co Ltd 抗けいれん剤
US5151497A (en) * 1989-02-21 1992-09-29 Japan Tobacco Inc. Histidyl peptide derivatives
CA2050425A1 (en) 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
ZA918168B (en) 1990-10-16 1993-04-14 Takeda Chemical Industries Ltd Prolonged release preparation and polymers thereof.
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
ES2110573T3 (es) 1992-08-07 1998-02-16 Takeda Chemical Industries Ltd Produccion de microcapsulas de farmacos solubles en agua.
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5837281A (en) 1995-03-17 1998-11-17 Takeda Chemical Industries, Ltd. Stabilized interface for iontophoresis
WO1997015301A1 (en) * 1995-10-24 1997-05-01 Gruenenthal Gmbh Method of adjusting the circadian rhythm of a mammal
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
US5908400A (en) * 1996-06-20 1999-06-01 Hisamitsu Pharmaceutical Co., Inc. Device structure for iontophoresis
KR100318804B1 (ko) * 1996-08-28 2002-01-04 시오노 요시히코 티아졸릴-알라닌 잔기를 갖는 신규한 펩티드 유도체
JP2001520222A (ja) * 1997-10-22 2001-10-30 ゼネカ・リミテッド イミダゾール誘導体およびファルネシルタンパク質トランスフェラーゼインヒビターとしてのそれらの使用
WO1999020611A1 (en) 1997-10-22 1999-04-29 Zeneca Limited Imidazole derivatives and their use as farnesyl protein transferase inhibitors
EP1268449A4 (en) * 2000-03-23 2004-09-15 Merck & Co Inc SUBSTITUTED PIPERIDINE AS MELANOCORTIN RECEPTOR AGONISTS
KR20050105290A (ko) * 2000-08-31 2005-11-03 시오노기세이야쿠가부시키가이샤 파킨슨씨병 치료제
AU2002224124A1 (en) 2000-12-01 2002-06-11 Takeda Chemical Industries Ltd. Method for producing preparation containing bioactive substance
GB0326632D0 (en) 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
US20130177651A1 (en) 2010-09-03 2013-07-11 Pharmaterials Limited Pharmaceutical Composition Suitable for Use in a Dry Powder Inhaler
JP6224586B2 (ja) 2012-07-10 2017-11-01 武田薬品工業株式会社 注射用製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753969A (en) * 1969-12-22 1973-08-21 K Folkers Method for synthesizing pyroglutamylhistidyl-prolinamide
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
DE2449167C2 (de) * 1974-10-16 1984-05-24 Grünenthal GmbH, 5190 Stolberg N-Acyl-L-histidyl-L-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
MY8500264A (en) 1985-12-31
US4100152A (en) 1978-07-11
ATA202377A (de) 1980-06-15
FR2345448A1 (fr) 1977-10-21
FR2345448B1 (sv) 1980-06-27
HU177515B (en) 1981-10-28
SG76083G (en) 1984-08-03
AU2354977A (en) 1978-09-28
CH634548A5 (de) 1983-02-15
DE2712086A1 (de) 1977-09-29
AU508387B2 (en) 1980-03-20
JPS5944308B2 (ja) 1984-10-29
SE430601B (sv) 1983-11-28
SE7703283L (sv) 1977-09-24
GB1579264A (en) 1980-11-19
JPS52116465A (en) 1977-09-29
NL188412C (nl) 1992-06-16
DE2712086C2 (de) 1986-04-03
DK149111B (da) 1986-01-27
NL188412B (nl) 1992-01-16
CA1060435A (en) 1979-08-14
GR62565B (en) 1979-05-10
ZA771495B (en) 1978-02-22
DK119577A (da) 1977-09-24
BE852740A (fr) 1977-07-18
DK149111C (da) 1986-06-09
AT360674B (de) 1981-01-26
NL7703115A (nl) 1977-09-27

Similar Documents

Publication Publication Date Title
HK27584A (en) Peptides
IL52014A0 (en) Polypeptide
GB1547911A (en) Polypeptides
AU2542577A (en) 4-amino-4-arylcyclohexanones
AU2384277A (en) Triazolo-pyrimidines
CS40277A2 (en) Zarovzdorna soucast pro nadoby obsahujici taveninu kovu
AU513702B2 (en) Peptides
JPS539761A (en) Peptide derivative
ZA783699B (en) Peptides
AU2662077A (en) 2-bromo-6fluoro-n-2-imidazolidinylidene-benzamine
AU2451277A (en) Isothiazolopyridines
AU2727977A (en) Peptides
JPS5312810A (en) Peptide derivatives
AU1309176A (en) Fire-barriers
ZA771789B (en) Polypeptide
CS886177A2 (en) Nabijeci zarizeni pro automatickou strelnou zbran
ZA774073B (en) Peptide derivatives
GB1541337A (en) Peptides
JPS52139023A (en) Peptide derivative
JPS52139022A (en) Peptide derivative
AU2493077A (en) 2-amino-substituted-isothioureido bewzenes
JPS5283553A (en) Peptide
AU2664077A (en) Frequency-synthesizer-tuner
AU2378777A (en) Amino - alkoxyalkanes
IE44099L (en) Peptides